drugset / Trial / NCT02333851

Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)

NCT02333851

RandomizedParallel-groupOpen-labelTreatment

Summary

Pilot study to compare the efficacy and safety of a premixed-insulin regimen (70% intermediate insulin and 30% regular insulin) to a basal-bolus insulin regimen (glargine once daily and glulisine before meals) hospitalized patients with type 2 diabetes.

Timeline

Start
2013-06
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin glulisine Protein / enzyme biologic
Subject Mixtard 30:70 Protein / enzyme biologic
Subject insulin glargine Protein / enzyme biologic